Article,
Deprescribing in primary care without deterioration of health-related outcomes: A real-life, quality improvement project
Affiliations
- [1] Aalborg University [NORA names: AAU Aalborg University; University; Denmark; Europe, EU; Nordic; OECD];
- [2] Aalborg University Hospital [NORA names: North Denmark Region; Hospital; Denmark; Europe, EU; Nordic; OECD];
- [3] Research Unit for General Practice [NORA names: Unclear Universities; University; Denmark; Europe, EU; Nordic; OECD]
Abstract
Medication reviews focusing on deprescribing can reduce potentially inappropriate medication; however, evidence regarding effects on health-related outcomes is sparse. In a real-life quality improvement project using a newly developed chronic care model, we investigated how a general practitioner-led medication review intervention focusing on deprescribing affected health-related outcomes. We performed a before–after intervention study including care home residents and community-dwelling patients affiliated with a large Danish general practice. The primary outcomes were changes in self-reported health status, general condition and functional level from baseline to 3–4 months follow-up. Of the 105 included patients, 87 completed the follow-up. From baseline to follow-up, 255 medication changes were made, of which 83% were deprescribing. Mean self-reported health status increased (0.55 [95% CI: 0.22 to 0.87]); the proportion with general condition rated as ‘average or above’ was stable (0.06 [95% CI: −0.02 to 0.14]); and the proportion with functional level ‘without any disability’ was stable (−0.05 [95% CI: −0.09 to 0.001]). In conclusion, this general practitioner-led medication review intervention was associated with deprescribing and increased self-reported health status without the deterioration of general condition or functional level in real-life primary care patients. The results should be interpreted carefully given the small sample size and lack of control group.